Your browser doesn't support javascript.
Computational-based drug repurposing methods in COVID-19.
Masoudi-Sobhanzadeh, Yosef.
  • Masoudi-Sobhanzadeh Y; Laboratory of Systems Biology and Bioinformatics (LBB), Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran.
Bioimpacts ; 10(3): 205-206, 2020.
Artículo en Inglés | MEDLINE | ID: covidwho-688945
ABSTRACT
COVID-19, as a newly emerging disease, has disrupted human's different activities. Hence, it is essential to develop drugs or vaccines in order to control COVID-19. Since there is not a medication or vaccine for treating the disease and drug development project is a time and cost consuming process, drug repurposing approaches may yield to proper curing plans. However, there are some limitations in this field, which make the process a challenging one. This letter aims to introduce drug repurposing methods and the existing challenges to detect candidate drugs which may be helpful in controlling COVID-19.
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Tópicos: Vacunas Idioma: Inglés Revista: Bioimpacts Año: 2020 Tipo del documento: Artículo País de afiliación: Bi.2020.25

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Tópicos: Vacunas Idioma: Inglés Revista: Bioimpacts Año: 2020 Tipo del documento: Artículo País de afiliación: Bi.2020.25